Bell Investment Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bell Investment Advisors’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.22K	Buy	6 +1	+20%	+$512	﹤0.01%	1160
2026 Q1	$2.62K	Sell	5 -3	-38%	-$1.43K	﹤0.01%	1226
2025 Q4	$4.66K	Buy	8 +3	+60%	+$1.53K	﹤0.01%	998
2025 Q3	$2.29K	Hold	5	–	–	﹤0.01%	1288
2025 Q2	$1.51K	Buy	5 +2	+67%	+$596	﹤0.01%	1453
2025 Q1	$994	Hold	3	–	–	﹤0.01%	1552
2024 Q4	$926	Hold	3	–	–	﹤0.01%	1610
2024 Q3	$637	Hold	3	–	–	﹤0.01%	1719
2024 Q2	$841	Hold	3	–	–	﹤0.01%	1656
2024 Q1	$802	Hold	3	–	–	﹤0.01%	1662
2023 Q4	$695	Hold	3	–	–	﹤0.01%	1703
2023 Q3	$439	Buy	+3	New	+$565	﹤0.01%	1842
2023 Q1	–	Sell	-5	Closed	-$1.45K	–	1957
2022 Q4	$1.45K	Buy	+5	New	+$489	﹤0.01%	1446

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bell Investment Advisors's MDGL Position: Q2 2026 in Review

Bell Investment Advisors increased its Madrigal Pharmaceuticals (MDGL) stake by 20% in Q2 2026, buying an estimated $512 and bringing the position to 6 shares worth $3.22K. The position accounts for ﹤0.01% of the portfolio, ranked #1160.

Bell Investment Advisors first reported a position in MDGL in Q4 2022 and has held it in 13 quarters since. The position peaked at $4.66K in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

Bell Investment Advisors held 6 shares of Madrigal Pharmaceuticals worth $3.22K as of Q2 2026.
Bell Investment Advisors bought 1 Madrigal Pharmaceuticals share in Q2 2026, an estimated $512.
Madrigal Pharmaceuticals made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #1160 holding.
Bell Investment Advisors first reported a position in Madrigal Pharmaceuticals in Q4 2022 and has held it in 13 quarters since.
Bell Investment Advisors's Madrigal Pharmaceuticals position peaked at $4.66K in Q4 2025.
414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.